voon ken fong, shing shen bay, muhammad yusuf abu shamsi, lydia kamaruzaman, ruslinda mustafar, wan syahira ellani wan ahmad kammal, nordashima abd shukor. (2024). sharpening glomerulonephritis diagnosis with electron microscope: case reports. - kidney international reports. 176.
the empa-kidney collaborative group, rizna abdul cader, ruslinda mustafar, lydia kamaruzaman, rozita mohd, rahimah ismail. (2024). impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the empa-kidney trial. - the lancet diabetes & endocrinology. 51-60.
rozita binti mohd;abdul halim bin abdul gafor;rizna abdul cader;kong wei yen;ruslinda binti mustafar. (2023). phase 3, randomized, open-label, active-controlled study evaluating the efficacy and safety of oral vadadustat for the maintenance treatment of anemia in subjects with non-dialysis-dependent chronic kidney disease (ndd-ckd) (pro2tect - conversion). - . .
lim kuan yee, wan rohaslizan wan daud, yusuf abu shamsi, wan syahira ellani wan ahmad kamal, ruslinda mustafar. (2023). severe crescentic lupus nephritis treated with plasma exchange and modified dose od immunosuppressive therapy. - medical journal of malaysia case reports. 30-33.
giritharan muniandy, lydia kamaruzaman, tan hui jan, rozita mohd, mariamutu theepa neesam, ken fong voon, beng pau kiew, ruslinda mustafar. (2023). cefepime induced encephalopathy in a non-dialysis dependent chronic kidney disease patient: a case report. - acta medica indonesiana. 78-82.
the empa-kidney collaborative group, rizna abdul cader, ruslinda mustafar, lydia kamaruzaman, rozita mohd, rahimah ismail. (2024). impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the empa-kidney trial. - the lancet diabetes & endocrinology. 51-60.
voon ken fong, shing shen bay, muhammad yusuf abu shamsi, lydia kamaruzaman, ruslinda mustafar, wan syahira ellani wan ahmad kammal, nordashima abd shukor. (2024). sharpening glomerulonephritis diagnosis with electron microscope: case reports. - kidney international reports. 176.
syahrul sazliyana shaharir, julia hanim jaafar, cheng lay teh, sharifah aishah wan akbar, c. yaw kiet, c. seow lin, b. sachdev manjit singh, adawiyah jamil, rozita mohd, ruslinda mustafar, sakthiswary rajalingham, mohd shahrir mohamed said, mohd talib. (2023). impact of solar radiation from sun exposure and photoprotection practices on disease activity among systemic lupus erythematosus (sle) patients in malaysia. - annals of the rheumatic diseases. 1516-1517.
nur aqeelah ahmad pouzi, syahrul sazliyana shaharir, azmi mohd tamil, ruslinda mustafar, suhaida ahmad maulana, eashwary mageswaren, wan syamimee wan ghazali. (2023). validation and the associated factors of the malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (sleqol and lupusqol). - plos one. 1-16.
m. s. mohamed said, s. chu ee, r. mustafa. (2023). retrospective study on sensitivity and specificity of various classification criteria in early diagnosis of systemic lupus erythematosus and link to disease outcomes. - annals of the rheumatic diseases. 1545.
ruslinda mustafar, khairun amalin mohd hishamuddin, rozita mohd, lydia kamaruzaman, wan haslina wan abdul halim, yong meng hsien, tan kuan sze, wan mimi diyana wan zaki, aziah ali and arbaiyah bain. (2023). retinal changes and cardiac biomarker assessment in relation to chronic kidney disease: a single centre study. - bmc nephrology. 1-12.
nur aqeelah ahmad pouzi, syahrul sazliyana shaharir, ruslinda mustafar, suhaida ahmad maulana, eashwary mageswaren, azmi mohd tamil, wan syamimee wan ghazali. (2023). validation of the malay version of systemic lupus erythematosus quality of life (sle qol) and lupus qol instruments. - international journal of rheumatic diseases. 284.
noor syazwani izyan a, abdul khalif adha, elena aisha azizan, nor azian abdul murad, noraidatulakma abdullah, mohd shahrir mohamed said, ruslinda mustafar, abdul halim abdul gafor, zarina abdul latiff, syahrul sazliyana. (2021). associations of the malaysian susceptibility gene loci of systemic lupus erythematosus (sle) with lupus nephritis and treatment response. - international journal of rheumatic diseases. 308-309.
chun yang sim, ching soong khoo, ruslinda mustafar, jia ning chai. (2021). a double whammy of mycotic aneurysms and acquired dysfibrinogenemia in a patient with septicemia. - balkan medical journal. 55-56.
syahrul s shaharir, suhaida a maulana, nor s shahril, rozita mohd, ruslinda mustafar, mohd s mohamed said and rahana a rahman. (2020). adverse pregnancy outcomes among multi-ethnic systemic lupus erythematosus patients in malaysia. - lupus. 1305-1313.
the empa-kidney collaborative group, rizna abdul cader, ruslinda mustafar, lydia kamaruzaman, rozita mohd, rahimah ismail. (2024). impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the empa-kidney trial. - the lancet diabetes & endocrinology. 51-60.
voon ken fong, shing shen bay, muhammad yusuf abu shamsi, lydia kamaruzaman, ruslinda mustafar, wan syahira ellani wan ahmad kammal, nordashima abd shukor. (2024). sharpening glomerulonephritis diagnosis with electron microscope: case reports. - kidney international reports. 176.
giritharan muniandy, lydia kamaruzaman, tan hui jan, rozita mohd, mariamutu theepa neesam, ken fong voon, beng pau kiew, ruslinda mustafar. (2023). cefepime induced encephalopathy in a non-dialysis dependent chronic kidney disease patient: a case report. - acta medica indonesiana. 78-82.
ang wan sin, teh rohaila jamil, rahmah kamaludin, ruslinda mustafar. (2023). ckd-check toolkit to improve doctors' practice in managing chronic kidney disease rapid progressors: a pilot study in primary care setting. - medical journal of malaysia. 721-732.
ruslinda mustafar, khairun amalin mohd hishamuddin, rozita mohd, lydia kamaruzaman, wan haslina wan abdul halim, yong meng hsien, tan kuan sze, wan mimi diyana wan zaki, aziah ali and arbaiyah bain. (2023). retinal changes and cardiac biomarker assessment in relation to chronic kidney disease: a single centre study. - bmc nephrology. 1-12.
ruslinda mustafar, lydia kamaruzaman, beh hui chien, azyani yahaya, noor'ain mohd nasir, rozita mohd, rizna cader, kong wei yen. (2019). top 25 clinical case reports. - . 12.
raja affendi raja ali, hayati yaakup, ruslinda mustafar, law zhe kang. (2013). orientation manual for house officer. - . :36.
wan haslina binti wan abdul halim;rozita binti mohd;ruslinda binti mustafar;yong meng hsien;lydia binti kamaruzaman;ayesha binti mohd zain. (2023). comparison of optical coherence tomography angiography parameters between diabetic chronic kidney disease and non-diabetic chronic kidney disease. - . .
yong meng hsien;wan haslina binti wan abdul halim;rozita binti mohd;ruslinda binti mustafar;ayesha binti mohd zain. (2023). comparison of retinal optical coherence tomography angiography parameters between patients with different causes of chronic kidney diseases. - . .
rozita binti mohd;abdul halim bin abdul gafor;rizna abdul cader;kong wei yen;ruslinda binti mustafar. (2023). phase 3, randomized, open-label, active-controlled study evaluating the efficacy and safety of oral vadadustat for the maintenance treatment of anemia in subjects with non-dialysis-dependent chronic kidney disease (ndd-ckd) (pro2tect - conversion). - . .
mohd shahrir bin mohamed said;ruslinda binti mustafar. (2023). retrospective study on sensitivity and specificity of 1997 acr revised criteria, boston weighted criteria, 2012 slicc classification criteria, and 2019 eular/acr classification criteria in systemic lupus erythematous and links to outcome and mortality. - . .
aliza mohamad yusof pn. norrafidah md sapuan, shareena ishak pn. siti fatkhiyah ,azarinah izaham pn. sumaiyah bt ismail, loh wayen en. mohd zulkifli mohd zain en. hairol azman bin mohamad yusop, ruslinda. (2022). policies and procedures on infection prevention and control hctm. - . 1-328.
| THE ROLE OF TOLVAPTAN AS AN ADJUNCTIVE THERAPY IN ACUTE DECOMPENSATED HEART FAILURE | otsuka pharmaceuticals (malaysia) sdn. bhd. | 21.5%(2024-08-26 sehingga 2026-02-25) |